PTC Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Cytokinetics -160545000 81.19M 2024-09
Daiichi Sankyo JPY 424.35B 67.89B 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Incyte USD 985.09M 111.22M 2025-03
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
TG Therapeutics USD 92.79M 18.25M 2024-12
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Xencor -45143000 40.69M 2024-09



PTC Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.